CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 218 enrolled
Drug / intervention
Emergency Stroke Unit based on 0.23-T MRI +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06492239
NCT06492239Phase 2Completed

Emergency Stroke Unit for Acute Cerebrovascular Events--A Prospective, Multicenter, Week-wise Randomized, Controlled Trial ( ESU-ACE-A )

Beijing Tiantan Hospital·interventional·Posted Jul 9, 2024·Updated Mar 4, 2025

In Brief

A Phase 2 clinical trial evaluating Emergency Stroke Unit based on 0.23-T MRI and Standard stroke unit adherent to guidelines for Ischemic Stroke, Acute. Completed, enrolled 218 participants across 1 site.

Detailed Summary

To compare the door-to-needle time of patients with hyperacute ischemic stroke (within 4.5 hours after the onset of symptoms) managed in a standard stroke unit adherent to guidelines versus managed in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

Phase 2CompletedFinished
20252026
First PostedJul 9, 2024
Enrollment StartJul 26, 2024
Primary CompletionJan 31, 2025
TodayJul 1, 2026
Enrollment to primary: 6 monthsPosted 2.0 years ago

Interventions

Emergency Stroke Unit based on 0.23-T MRIcombination

The participants with hyperacute ischemic stroke (symptoms onset ≤4.5 h) who are eligible to receive reperfusion therapy will be managed by Emergency Stroke Unit process based on low-field magnetic resonance imaging.

Standard stroke unit adherent to guidelinescombination

The participants with hyperacute ischemic stroke (symptoms onset ≤4.5 h) who are eligible to receive reperfusion therapy will be managed by standard stroke unit process adherent to guidelines.